Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ABVX
ABVX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ABVX News
Three High-Potential Stocks: Abivax, Krystal Biotech, and Marvell
11h ago
Fool
Abivax, Krystal Biotech, and Marvell's Market Potential
11h ago
NASDAQ.COM
Abivax Completes $920M Public Offering with Full Underwriter Option Exercise
6d ago
seekingalpha
Abivax Increases Offering to 7.36 Million Shares, Raising $874.1 Million
6d ago
stocktwits
Abivax Fully Exercises Underwriters' Option for Additional ADS Purchase
6d ago
Newsfilter
Abivax Raises $800 Million Through ADS Offering
6d ago
stocktwits
ABIVAX Prices Public Offering of 6.4 Million ADSs
6d ago
NASDAQ.COM
Abivax Prices Oversubscribed $800M Public Offering
6d ago
Newsfilter
Abivax Upsizes Public Offering to $800M, Plans for Obefazimod Commercialization
6d ago
seekingalpha
Latest Wall Street Rating Updates
6d ago
CNBC
Abivax's Ulcerative Colitis Data Boosts Analyst Outlook
Jul 01 2026
CNBC
Abivax Temporarily Halts Trading on Euronext Paris
Jul 01 2026
NASDAQ.COM
Abivax Announces Temporary Trading Halt on Euronext Paris
Jul 01 2026
Newsfilter
Biotech Companies See Significant Stock Gains
Jul 01 2026
NASDAQ.COM
Abivax Raises Price Target and Launches $600 Million Public Offering
Jul 01 2026
stocktwits
Abivax Launches $600 Million Public Offering of ADS
Jun 30 2026
Newsfilter
Show More News
